JP Morgan Chase’s Burning Rock Biotech BNR Stock Holding History
Bought
Maintained
Sold
Other funds holding BNR
KCM
CL
NAMA
RWMG
HH
JP Morgan Chase's BNR Position: Q1 2026 in Review
JP Morgan Chase opened a new position in Burning Rock Biotech (BNR) in Q1 2026: 187 shares worth $2.99K. The stake represents ﹤0.01% of the portfolio and ranks #6954 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in BNR as recently as Q3 2025.
JP Morgan Chase first reported a position in BNR in Q2 2020 and has held it in 16 quarters since. The position peaked at $13.3M in Q2 2020. 16 funds tracked by Wall St. Rank hold BNR as of Q1 2026.
- JP Morgan Chase held 187 shares of Burning Rock Biotech worth $2.99K as of Q1 2026.
- Burning Rock Biotech was a new JP Morgan Chase position in Q1 2026.
- Burning Rock Biotech made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6954 holding.
- JP Morgan Chase first reported a position in Burning Rock Biotech in Q2 2020 and has held it in 16 quarters since.
- JP Morgan Chase's Burning Rock Biotech position peaked at $13.3M in Q2 2020.
- 16 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.